Additionally, peridinin interferes with inflammatory and oncogenic signaling mediated by NF‐κB. Biochemical studies show that peridinin inhibits Akt‐mediated activation of IKK, with a subsequent reduction in NF‐κB activation and the expression of its downstream gene products important for both cancer progression and inflammatory responses. Here, NFKB1 is linked to cancer.